Evidence map›Paper›PMID 33677815›Full record

ArticleHuman cell2021

Isolation of adipose tissue-derived stem cells by direct membrane migration and expansion for clinical application.

Yoshinobu Matsuo, Hiromichi Morita, Hisakazu Yamagishi, Mitsutoshi Nakamura, Yasuhiro Takeshima, Ichiro Nakagawa, Jiro Imanishi, Takahiro Tsujimura

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yoshinobu MatsuoDivision of Cell Therapy Research, U-Medics, Inc, Matsui 8-1, Utano, Uda, Nara, 633-2221, Japan. matsuo@grandsoul.co.jp.
Hiromichi MoritaCellular Biology, Grandsoul Research Institute for Immunology, Inc, Matsui 8-1, Utano, Uda, Nara, 633-2221, Japan.
Hisakazu YamagishiResearch and Development Center for Regenerative Medicine, Matsui 8-1, Utano, Uda, Nara, 633-2221, Japan.
Mitsutoshi NakamuraGrandsoul Nara Clinic, Matsui 8-1, Utano, Uda, Nara, 633-2221, Japan.
Yasuhiro TakeshimaDepartment of Neurosurgery, Nara Medical University, Kashihara, Nara, 634-8522, Japan.
Ichiro NakagawaDepartment of Neurosurgery, Nara Medical University, Kashihara, Nara, 634-8522, Japan.
Jiro ImanishiMeiji University of Integrative Medicine, Nantan-City, Kyoto, 629-0392, Japan.
Takahiro TsujimuraDivision of Cell Therapy Research, U-Medics, Inc, Matsui 8-1, Utano, Uda, Nara, 633-2221, Japan.
Nara City Hospital · JPNara Medical University · JPMeiji University of Integrative Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) have recently made significant progression in multiple clinical trials targeting several clinical disorders and in the modulation of immune responses. In the present study, we isolated human adipose tissue-derived stem cells (ADSCs) by direct membrane migration method without using enzymatic digestion via collagenase, and tried to extract adequate number of cells for clinical application. Hydroxyapatite-treated nonwoven fabric membrane made up of synthetic macromolecular fiber materials, polyethylene and polyester terephthalene was used. Expansion culture of ADSCs having plastic flask adherent characteristic in serum-free condition was successfully established, and adequate number of cells were obtained for clinical application. They were found to be positive for CD44, CD73, CD90 and CD105 and negative for CD11b, CD34, CD45, CD80 and HLA-DR. The resulting immunological marker profile satisfied the immunophenotype of previously reported MSCs. Also, microscopic findings demonstrated trilineage differentiation into adipogenic, osteogenic and chondrogenic cells as the characteristics of MSCs. The isolation by nonwoven fabric membrane and expanded cells under serum-free condition satisfied the criteria of MSCs, as proposed by the International Society for Cellular Therapy. Our direct membrane migration method without enzyme digestion is useful as ADSCs can be obtained from small pieces of adipose tissue and expanded under serum-free culture condition. This method was considered to be feasible for clinical application.

Indexed as

Membranes, ArtificialMesenchymal Stem CellsAdipose TissueAntigens, CDCells, CulturedCell SeparationCulture Media, Serum-FreeDurapatiteHumansPolyestersPolyethyleneAntigens, CDCulture Media, Serum-FreeDurapatiteMembranes, ArtificialPolyestersPolyethyleneHydroxyapatiteMesenchymal stem cellsMigrationNonwoven fabric membraneSerum-free culture

Identifiers

PMID33677815
OpenAlexW3134987721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.